256 related articles for article (PubMed ID: 22805860)
1. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma.
Li K; Wang RW; Jiang YG; Zou YB; Guo W
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694
[TBL] [Abstract][Full Text] [Related]
3. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
4. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
5. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
[TBL] [Abstract][Full Text] [Related]
6. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
[TBL] [Abstract][Full Text] [Related]
7. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
8. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
9. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
10. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
11. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
[TBL] [Abstract][Full Text] [Related]
12. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
[TBL] [Abstract][Full Text] [Related]
13. Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma.
Shibata T; Matsuo Y; Shamoto T; Hirokawa T; Tsuboi K; Takahashi H; Ishiguro H; Kimura M; Takeyama H; Inagaki H
Oncol Rep; 2013 Jun; 29(6):2127-32. PubMed ID: 23588413
[TBL] [Abstract][Full Text] [Related]
14. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
[TBL] [Abstract][Full Text] [Related]
15. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
[TBL] [Abstract][Full Text] [Related]
19. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
20. SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.
Akagi I; Miyashita M; Makino H; Nomura T; Hagiwara N; Takahashi K; Cho K; Mishima T; Takizawa T; Tajiri T
Ann Surg Oncol; 2008 Oct; 15(10):2965-75. PubMed ID: 18612694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
